Literature DB >> 19846119

Clinical manifestations, diagnostic criteria and therapy of Hashimoto's encephalopathy: report of two cases.

Milija Mijajlovic1, Mihailo Mirkovic, Jelena Dackovic, Jasna Zidverc-Trajkovic, Nadezda Sternic.   

Abstract

Hashimoto's encephalopathy (HE) is a rare, still not well understood, autoimmune disease with neurological and psychiatric manifestations. and elevated titers of antithyroid antibodies in serum and cerebrospinal fluid (CSF) as a hallmark of the disease. Patients are mostly women. Current diagnostic criteria include corticosteroide responsiveness, but it is the case in only 50% of patients with HE. In steroid non-responders other immunomodulatory therapies or plasmapheresis could be applied. Disease course can be acute, subacute, chronic or relapsing-remitting. Two distinct forms emerged from the reported cases: a vasculitic type characterized by multiple relapsing-remitting stroke-like episodes and mild cognitive impairment and a diffuse progressive type characterized by dementia and psychiatric symptoms. Both forms may be accompanied by depressed level of consciousness (stupor or coma), tremor, seizures, or myoclonus. We present two patients with two distinct forms of HE who had different clinical manifestations and response to therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19846119     DOI: 10.1016/j.jns.2009.09.030

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  12 in total

1.  An unusual case of stroke.

Authors:  Michael Rosario; Sarah Xianyuan Song; Louise D McCullough
Journal:  Neurologist       Date:  2012-07       Impact factor: 1.398

2.  Successful response to intravenous immunoglobulin as rescue therapy in a patient with Hashimoto's encephalopathy.

Authors:  Rodrigo Cornejo; Pablo Venegas; Daniela Goñi; Alvaro Salas; Carlos Romero
Journal:  BMJ Case Rep       Date:  2010-12-29

Review 3.  Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT): case report of reversible coma and status epilepticus in an adolescent patient and review of the literature.

Authors:  Johannes M Hilberath; Heinrich Schmidt; Gerhard K Wolf
Journal:  Eur J Pediatr       Date:  2014-08-02       Impact factor: 3.183

4.  Hashimoto encephalopathy: A study of the clinical profile, radiological and electrophysiological correlation in a Tertiary Care Center in South India.

Authors:  Pattanagere Manjunatha Suryanarayana Sharma; Mahendra Javali; Rohan Mahale; Byadarahalli Kempegowda Madhusudhan; Anas Abdul Majeed; Rangasetty Srinivasa
Journal:  J Neurosci Rural Pract       Date:  2015 Jul-Sep

5.  Hashimoto's Encephalitis: Unusual Cause of Reversible Dementia.

Authors:  Kuljeet Singh Anand; Jyoti Garg; Rohit Verma; Anirban Chakraborty
Journal:  J Family Med Prim Care       Date:  2014-07

Review 6.  Psychiatric Presentations Heralding Hashimoto's Encephalopathy: A Systematic Review and Analysis of Cases Reported in Literature.

Authors:  Vikas Menon; Karthick Subramanian; Jaiganesh Selvapandian Thamizh
Journal:  J Neurosci Rural Pract       Date:  2017 Apr-Jun

7.  Cognitive impairments in Hashimoto's encephalopathy: a case-control study.

Authors:  Jianhong Wang; Jun Zhang; Lan Xu; Yunbo Shi; Xunyi Wu; Qihao Guo
Journal:  PLoS One       Date:  2013-02-08       Impact factor: 3.240

8.  Steroid-Responsive Epilepsia Partialis Continua with Anti-Thyroid Antibodies: A Spectrum of Hashimoto's Encephalopathy?

Authors:  Hiroki Masuda; Masahiro Mori; Shoichi Ito; Toshiyuki Yagishita; Satoshi Kuwabara
Journal:  Case Rep Neurol       Date:  2014-05-17

9.  Encephalopathy Associated with Autoimmune Thyroid Disease: A Potentially Reversible Condition.

Authors:  Inês Correia; Inês B Marques; Rogério Ferreira; Lívia Sousa
Journal:  Case Rep Med       Date:  2016-04-05

10.  Hashimoto Encephalopathy in Case of Progressive Cognitive Impairment; a Case Report.

Authors:  Abbas Tafakhori; Bahaadin Siroos; Mojdeh Ghabaii; Mohammad Hossein Harirchain; Masih Tajdini; Sushil Kumar Garg
Journal:  Emerg (Tehran)       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.